Englemed is a specialist on-line news agency. We have provided feeds of medical and health news for 16 years to a range of customers. Our major client is currently Doctors_net_uk, the leading social media site for doctors. If you are interested in developing a specialist news service, please contact us. Although our business is mainly with professional clients, our background is in news and we can produce newsfeeds in plain English for a lay audience.
Innovative cancer drugs delayed
Wednesday January 29th, 2020
The licensing of the most innovative cancer treatments is taking longer than necessary, depriving many patients of potential care, a British expert alleges today.
The report is released today (29 January) by The Institute of Cancer Research, London, UK. It examines the time taken to pass through clinical trials, licensing and appraisal for availability on the NHS, for innovative versus more conventional cancer treatments.
Study leader Professor Paul Workman and his team found that the higher the level of innovation of a cancer drug, the longer this process takes. The researchers analysed the reasons why the system of drug discovery and development appears to be risk averse to innovative drugs, which ”play an essential role in tackling cancer evolution and drug resistance - the biggest challenge in cancer research and treatment today”.
Down syndrome genes unveiled
Wednesday January 29th, 2020
Multiple genes are responsible for the problems associated with Down syndrome, British researchers reported last night. More
Lung improvements seen after obesity surgery
Wednesday January 29th, 2020
The shortness of breath caused by obesity can be reversed with weight loss surgery, British doctors have reported. More
Anastrozole recommended for some post-menopausal women to stop cancer
Range of health risks from asthma in pregnancy
Exercise labels on food may improve choices
How marathon runners roll back years